ArticleHepatology (Baltimore, Md.)2018

Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis.

Ruben Hernaez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.